Assisted reproductive technology in late reproductive age women with polycystic ovarian syndrome


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: To compare the efficiency of frozen-thawed embryo transfer after preimplantation genetic testing for aneuploidy (PGT-A) in late reproductive age women with polycystic ovarian syndrome (PCOS) and those with tubal-peritoneal factor infertility. Materials and methods: The study included 63 infertile women of late reproductive age undergoing IVF/ICSI with gonadotropin-releasing hormone (GnRH) antagonists followed by PGT-A. The patients were divided into Group 1 including women with tubal-peritoneal infertility (n=30) and Group 2 including women with PCOS (n=33). Then, all the patients included in this study underwent frozen-thawed embryo transfer, providing the availability of embryos recommended for transfer by genetic testing. The effectiveness of the ART program was evaluated by the rates of achieved pregnancy, biochemical pregnancy rate, ectopic pregnancy rate, spontaneous miscarriage rate, missed miscarriage rate, and live birth rates. Results: There were no differences in IVF/ICSI efficacy between the two study groups. A total of9/27 (33.3%) pregnancies were recorded in the tubal-peritoneal factor group versus 8/25 (32%) in the PCOS group (p=0.919), a difference that was not statistically significant [OR 1.042 (CI0.48; 2.28), p=0.919]. Of them, 5/27 (18.5%) and 4/25 (16%) ended in birth [OR 1.157 (CI 0.35; 3.83), p=0.811] and 6/27(22.2%) and 4/25 (16%) resulted in miscarriage [OR 1.39 (CI 0.44; 4.35), p=0.569]. There was only one miscarriage (3.7%) in the group of patients with tubal-peritoneal infertility factor. Conclusion: In late reproductive age, patients with both PCOS and tubal-peritoneal infertility factor, IVF/ICSI and PGT-A programs followed by frozen-thawed embryo transfer demonstrated similar efficacy. Despite the higher ovarian reserve, the efficacy of ART programs in patients with PCOS also decreases with age, requiring PGT-A in older patients, regardless of the infertility factor. Further studies of this problem on a larger sample of patients are needed.

Full Text

Restricted Access

About the authors

Nina D. Mikhailova

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: mihailnina@mail.ru
PhD. Student at the lst Gynecology Department

Artem A. Aksenenko

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: a_axenenko@oparina4.ru
Gynecologist at the lst Gynecology Department

Evelina R. Durinyan

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e_durinyan@oparina4.ru
Ph.D., Clinical Care Supervisor at the lst Gynecological Department

Alla A. Gavisova

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: gavialla@yandex.ru
Ph.D., Senior Researcher at the lst Gynecological Department.

References

  1. Lizneva D., Suturina L., Walker W., Brakta S., Gavrilova-Jordan L., Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 2016; 106(1): 6-15. https://dx.doi.org/10.1016/j.fertnstert.2016.05.003.
  2. Назаренко Т.А., Корнеева И.Е., Мишиева Н.Г. Клинические рекомендации. Синдром гиперстимуляции яичников: диагностика, лечение, профилактика, интенсивная терапия». М.: Российское общество акушеров-гинекологов; 2018.
  3. Dumesic D.A., Padmanabhan V., Abbott D.H. Polycystic ovary syndrome and oocyte developmental competence. Obstet. Gynecol. Surv. 2008; 63(1): 39-48. https://dx.doi.org/10.1097/OGX.0b013e31815e85fc.
  4. Qiao J., Feng H.L. Extraand intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum. Reprod. Update. 2011; 17(1): 17-33. https://dx.doi.org/10.1093/humupd/dmq032.10.
  5. Мартазанова Б.А., Мишиева Н.Г., Абубакиров А.Н. Замена триггера овуляции как метод профилактики развития синдрома гиперстимуляции яичников. Акушерство и гинекология. 2014; 5: 15-8.
  6. Мартазанова Б.А., Мишиева Н.Г., Левков Л.А., Грачева А.М., Богатырева Х.А., Ипен С.М., Лапина В.С., Абубакиров А.Н. Оптимизация программ экстракорпорального оплодотворения путем замены триггера овуляции. Акушерство и гинекология. 2015; 10: 73-80.
  7. Yang W., Yang R., Yang S., Li J., Tu B., Gao C. et al. Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism. Gynecol. Endocrinol. 2018; 34(8): 715-8. https://dx.doi.org/10.1080/09513590.2018.1431773.
  8. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Fertil. Steril. 2018; 109(3): 429-36. https://dx.doi.org/10.1016/j.fertnstert.2018.01.002.
  9. Мишиева Н.Г., Назаренко Т.А., Дуринян Э.Р., Чечурова Т.Н., Смирнова А.А. Эндокринные и метаболические нарушения при СПКЯ и их значение для здоровья пациенток. Синдром поликистозных яичников (современные подходы к диагностике и лечению бесплодия). М.: МЕДпресс-информ; 2005: 83-91.
  10. Pearson H., Abittan B., Goldman R.H., Mullin C. Preimplantation genetic testing for aneuploidy confers greater benefit to young patients with polycystic ovarian syndrome. Fertil. Steril. 2020; 114(3): e422-3. https://dx.doi.org/10.1016/j.fertnstert.2020.08.1229.
  11. Михайлова Н.Д., Аксененко А.А., Ибрагимова М.Х., Екимов А.Н., Гависова А.А. Эффективность программ вспомогательных репродуктивных технологий с проведением преимплантационного генетического тестирования на анеуплоидии у женщин с синдромом поликистозных яичников. Акушерство и гинекология. 2022; 7: 60-7. https://dx.doi.org/10.18565/aig.2022.7.60-67.
  12. Legro R.S., Arslanian S.A., Ehrmann D.A., Hoeger K.M., Murad M.H., Pasquali R. et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2013; 98(12): 4565-9. https://dx.doi.org/10.1210/jc.2013-2350.
  13. Costello M.F., Garad R.M., Hart R., Homer H., Johnson L., Jordan C. et al. A review of secondand third-line infertility treatments and supporting evidence in women with polycystic ovary syndrome. Med. Sci. (Basel). 2019; 7(7): 75. https://dx.doi.org/10.3390/medsci7070075.
  14. Gordon C.E., Keefe K.W., Ginsburg E.S., Racowsky C., Lanes A. Embryo attrition in planned PGT-A: predicting the number of available blastocysts for transfer. J. Assist. Reprod. Genet. 2022; 39(1): 173-81. https://dx.doi.org/10.1007/s10815-021-02365-0.
  15. Колода Ю.А., Подзолкова Н.М., Петриченко Ю.Г. Прогнозирование исходов и выбор оптимальной тактики в программах вспомогательных репродуктивных технологий при синдроме поликистозных яичников. Акушерство и гинекология. 2021; 2: 84-9. [Koloda Yu.A., Podzolkova N.M., Petrichenko Yu.G. Prediction of ART outcomes and treatment of choice in PCOS patients. Obstetrics and Gynecology. 2021; 2: 84-9. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.2.84-89.
  16. Li J., Liu X., Hu L., Zhang F., Wang F., Kong H. et al. A slower age-related decline in treatment outcomes after the first ovarian stimulation for in vitro fertilization in women with polycystic ovary syndrome. Front. Endocrinol. (Lausanne). 2019; 10: 834. https://dx.doi.org/10.3389/fendo.2019.00834.
  17. Luo L., Gu F., Jie H., Ding C., Zhao Q., Wang Q. et al. Early miscarriage rate in lean polycystic ovary syndrome women after euploid embryo transfer -a matched-pair study. Reprod. Biomed. Online. 2017; 35(5): 576-82. https://dx.doi.org/10.1016/j.rbmo.2017.07.010.
  18. Li Y., Wang L., Xu J., Niu W., Shi H., Hu L. et al. Higher chromosomal aberration rate in miscarried conceptus from polycystic ovary syndrome women undergoing assisted reproductive treatment. Fertil. Steril. 2019; 111(5): 936-43. e2. https://dx.doi.org/10.1016/j.fertnstert.2019.01.026.
  19. Savaris R.F., Groll J.M., Young S.L., DeMayo F.J., Jeong J.W., Hamilton A.E. et al. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. J. Clin. Endocrinol. Metab. 2011; 96(6): 1737-46. https://dx.doi.org/10.1210/jc.2010-2600.
  20. Roque M., Haahr T., Geber S., Esteves S.C., Humaidan P. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and metaanalysis of reproductive outcomes. Hum. Reprod. Update. 2019; 25(1): 2-14. https://dx.doi.org/10.1093/humupd/dmy033.
  21. Qiu M., Tao Y., Kuang Y., Wang Y. Effect of body mass index on pregnancy outcomes with the freeze-all strategy in women with polycystic ovarian syndrome. Fertil. Steril. 2019; 112(6): 1172-9. https://dx.doi.org/10.1016/j.fertnstert.2019.08.009.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies